U.S. markets closed

Claritas Pharmaceuticals, Inc. (CLAZF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.1000+0.0364 (+57.36%)
At close: 03:30PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0636
BidN/A x N/A
AskN/A x N/A
Day's Range0.0300 - 0.1000
52 Week Range0.0039 - 0.2419
Avg. Volume1,432
Market Cap3.659M
Beta (5Y Monthly)2.55
PE Ratio (TTM)1.11
EPS (TTM)0.0900
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CLAZF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    The Argus ESG Model PortfolioSustainable Impact Investing, or ESG investing, is gaining traction not only with Argus Research clients but also with the global investment community. BlackRock CEO Lawrence Fink, who oversees approximately $9 trillion in assets, announced in January 2020 that his firm would be investing in companies that are making progress on sustainability. He doubled down in his January 2021 letter, calling on company managements to disclose their plans for making their businesses "compatible with a net-zero economy" by 2050. As assets have flowed in over the past 40 years, Sustainable Impact Investing has evolved. The discipline, originally known as Socially Responsible Investing, focused at first on excluding companies that conducted business in South Africa, or participated in industries such as tobacco, alcohol, and firearms. Performance of these initial strategies lagged, and the approach has been modified. Now, instead of merely identifying industries to avoid, the discipline promotes "sustainable" business practices across all industries that can have an "impact" on global issues such as climate, hunger, poverty, disease, shelter, and workers' rights.
    Fair Value
    Economic Moat
    7 hours agoArgus Research
View more
  • CNW Group

    IIROC Trading Halt - CLAS

    The following issues have been halted by IIROC:

  • CNW Group

    IIROC Trading Halt - CLAS.WT.B

    The following issues have been halted by IIROC:

  • GlobeNewswire

    Claritas Announces Approval from OTC to Up-List to OTCQB

    SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") is pleased to announce that it has obtained approval from the OTC Markets Group for listing of its Common Shares on the OTCQB. The Company will provide an update regarding the exact date on which its Common Shares will begin trading on the OTCQB under the ticker symbol "CLAZF". Highlights Claritas has received approval from